DIAZEPAM INTERACTION WITH ANTI-TUBERCULOSIS DRUGS

被引:61
作者
OCHS, HR [1 ]
GREENBLATT, DJ [1 ]
ROBERTS, GM [1 ]
DENGLER, HJ [1 ]
机构
[1] TUFTS UNIV,NEW ENGLAND MED CTR,DIV CLIN PHARMACOL,BOSTON,MA 02111
关键词
D O I
10.1038/clpt.1981.94
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:671 / 678
页数:8
相关论文
共 18 条
  • [1] CLINICAL PHARMACOKINETICS OF RIFAMPICIN
    ACOCELLA, G
    [J]. CLINICAL PHARMACOKINETICS, 1978, 3 (02) : 108 - 127
  • [2] BREIMER DD, 1977, CLIN PHARMACOL THER, V21, P470
  • [3] EDWARDS OM, 1974, LANCET, V2, P549
  • [4] ENTRY OF DIAZEPAM AND ITS MAJOR METABOLITE INTO CEREBROSPINAL-FLUID
    GREENBLATT, DJ
    OCHS, HR
    LLOYD, BL
    [J]. PSYCHOPHARMACOLOGY, 1980, 70 (01) : 89 - 93
  • [5] DRUG-THERAPY - CLINICAL PHARMACOKINETICS .1.
    GREENBLATT, DJ
    KOCHWESER, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (14) : 702 - 705
  • [6] DRUG-THERAPY - CLINICAL PHARMACOKINETICS .2.
    GREENBLATT, DJ
    KOCHWESER, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (19) : 964 - 970
  • [7] DIAZEPAM DISPOSITION DETERMINANTS
    GREENBLATT, DJ
    ALLEN, MD
    HARMATZ, JS
    SHADER, RI
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (03) : 301 - 312
  • [8] GREENBLATT DJ, 1978, CLIN CHEM, V24, P1838
  • [9] PHARMACOKINETICS AND BIOAVAILABILITY OF INTRAVENOUS, INTRAMUSCULAR, AND ORAL LORAZEPAM IN HUMANS
    GREENBLATT, DJ
    SHADER, RI
    FRANKE, K
    MACLAUGHLIN, DS
    HARMATZ, JS
    ALLEN, MD
    WERNER, A
    WOO, E
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (01) : 57 - 63
  • [10] LAROUSSE C, 1980, INT J CLIN PHARM TH, V18, P163